Display options
Share it on

JAAD Case Rep. 2016 Jul 27;2(4):290-3. doi: 10.1016/j.jdcr.2016.06.004. eCollection 2016 Jul.

Pembrolizumab-associated sarcoidosis.

JAAD case reports

Jonathan Cotliar, Christiane Querfeld, William J Boswell, Naveen Raja, Dan Raz, Robert Chen

Affiliations

  1. Division of Dermatology, City of Hope National Medical Center, Duarte, California.
  2. Cutaneous Lymphoma Program & Dermatopathology, Toni Stephenson Lymphoma Center, City of Hope National Medical Center, Duarte, California.
  3. Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, California.
  4. Division of Rheumatology, City of Hope National Medical Center, Duarte, California.
  5. Lung Cancer and Thoracic Oncology Program, Division of Thoracic Surgery, City of Hope National Medical Center, Duarte, California.
  6. Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.

PMID: 27504482 PMCID: PMC4969257 DOI: 10.1016/j.jdcr.2016.06.004

[No abstract available.]

Keywords: FDG, fludeoxyglucose; PD-1, programmed cell death-1; lymphoma; pembrolizumab; programmed cell death-1; sarcoidosis

References

  1. J Eur Acad Dermatol Venereol. 2016 Oct;30(10 ):e89-e91 - PubMed
  2. Muscle Nerve. 2016 Jun;54(1):157-61 - PubMed
  3. J Am Acad Dermatol. 2016 Mar;74(3):455-61.e1 - PubMed
  4. J Immunother. 2016 May;39(4):188-90 - PubMed
  5. Clin Cancer Res. 2016 Aug 15;22(16):4023-9 - PubMed
  6. JAMA Dermatol. 2015 Nov;151(11):1206-12 - PubMed
  7. Acta Derm Venereol. 2016 Feb;96(2):259-60 - PubMed
  8. Ann Oncol. 2015 Dec;26(12):2375-91 - PubMed
  9. JAMA Dermatol. 2015 Jul;151(7):797-9 - PubMed
  10. Cancer Immunol Res. 2016 May;4(5):383-9 - PubMed

Publication Types